Post AMI management: mini audit

This activity supports general practitioners to review and update their management of patients following myocardial infarction in line with recent Australian Heart Foundation guideline updates. Emerging evidence has led to important changes in secondary prevention, particularly regarding the duration and indication for beta-blocker therapy in patients with preserved left ventricular function, as well as increasing recognition of clopidogrel as a suitable long-term alternative to aspirin for selected patients.

Participants will review contemporary evidence and guideline recommendations for post-MI care, including documentation of MI type and investigations, reassessment of left ventricular function, indications for ongoing beta-blocker use, antiplatelet selection, lipid targets, and comprehensive cardiovascular risk management. The activity encourages reflection on how current recommendations differ from historical practice and how these changes apply to patients commonly managed in general practice.

Through a structured mini audit of post-MI patients, participants will assess current management against best practice standards, identify gaps in documentation or treatment, and consider opportunities for optimisation such as beta-blocker deprescribing, individualisation of antiplatelet therapy, and escalation of lipid-lowering therapy where indicated. Reflection on audit findings supports implementation of evidence-based changes and strategies to sustain improvement in future care.

This activity provides 0.5 hour of EA, 0.5 hour of RP and 2.5 hours of MO and sits alongside our upcoming hot topics webinar which you can register for here.